WINT

Windtree Therapeutics

Delisted

WINT was delisted on the 20th of August, 2025.

5 hedge funds and large institutions have $57K invested in Windtree Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-6
Holders Change %
-54.55%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
UBS Group
1
UBS Group
Switzerland
$36.2K +$34.7K +27,573 +2,313%
Morgan Stanley
2
Morgan Stanley
New York
$18.9K +$18.9K +15,000 New
TRCT
3
Tower Research Capital (TRC)
New York
$1.73K +$1.62K +1,286 +1,429%
Bank of America
4
Bank of America
North Carolina
$126 +$125 +99 +9,900%
SS
5
SBI Securities
Japan
$30 +$29 +23 +2,300%
Renaissance Technologies
6
Renaissance Technologies
New York
-$41.7K -2,385 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
-$20.7K -1,183 Closed
XT
8
XTX Topco
Cayman Islands
-$6.8K -389 Closed
Two Sigma Investments
9
Two Sigma Investments
New York
-$5.05K -289 Closed
CSS
10
Cubist Systematic Strategies
Connecticut
-$4.78K -274 Closed
Goldman Sachs
11
Goldman Sachs
New York
-$4.31K -247 Closed
HF
12
HRT Financial
New York
-$3K -221 Closed
AWM
13
Activest Wealth Management
Florida
-$1
BlackRock
14
BlackRock
New York
-$2